Purpose: To investigate the relationship between central corneal thickness (CCT) and diabetes disease severity among patients with diabetic peripheral neuropathy (DPN) compared with controls.
D
iabetes mellitus (DM) causes numerous metabolic, structural, and functional changes in various organs. Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic diabetes complications. 1 Although DPN rates are very low in patients with early type 1 diabetes, these rates are higher in patients with newly diagnosed type 2 diabetes and increase with diabetes duration as a function of glucose control and other risk factors including blood pressure and blood lipid levels. [1] [2] [3] DPN results from progressive damage and loss of myelinated and unmyelinated nerve fibers causing pain, numbness, and tingling. 1 In severe cases, DPN can lead to complications such as foot ulceration and amputation.
In addition to well-recognized ocular complications of DM, such as diabetic retinopathy, cataract progression, and neovascular glaucoma, DM impacts multiple ocular tissues including the cornea. Corneal manifestations in diabetes include recurrent corneal erosion, punctate keratopathy, persistent epithelial defect, increased susceptibility to ulceration, reduced corneal sensation, and neurotrophic ulceration. 4, 5 There are also changes in central corneal thickness (CCT) among patients with diabetes. Several studies report an increase in CCT among patients with diabetes. [6] [7] [8] [9] [10] [11] Increased CCT has clinical implications in intraocular pressure (IOP) assessment, glaucoma progression, and protection against ectasia. 12, 13 Although previous studies have established an association between CCT and DM, none have evaluated the relationship between DPN severity and CCT despite the known associations of DPN with ocular manifestations. [14] [15] [16] The purpose of this study was to test the hypothesis that there is a direct association between CCT and diabetic neuropathy severity. This study assessed corneal thickness in association with DPN severity in a well-defined cohort with DPN compared with controls. Furthermore, this study was designed to identify the layer of the cornea most affected by DPN status in an effort to consider the mechanism underlying increased CCT reported in previous studies.
MATERIALS AND METHODS

Study Design
This was a cross-sectional study performed at the University of Michigan, Kellogg Eye Center. The study was approved by the Institutional Review Board at the University of Michigan, and written informed consent was obtained from each patient before testing. This study adhered to the tenets of the Declaration of Helsinki.
Study participants were recruited from the outpatient clinics of the Division of Metabolism, Endocrinology and Diabetes at the University of Michigan Health System and included in 3 groups: patients with diabetes and mild DPN, patients with diabetes and severe DPN, and healthy controls. Inclusion criteria were age 18 years and older, presence of diabetes defined by the American Diabetes Association for the group with diabetes, 17 and having at least some evidence of DPN for the group with diabetes. DPN presence and severity were assessed using nerve conduction studies (NCSs) and quantitative sensory testing (QST) by a multidisciplinary team using a standardized and validated protocol. 18 Participants were classified as having mild DPN if they had the following: 1) abnormal neurological examination performed by a board-certified neurologist confirmed by abnormal QST and 2) the presence of 1 mild abnormal attribute (of amplitude, latency, F-wave, or nerve conduction velocity) in 1 or more separate nerves among the median, peroneal, and sural nerves in NCSs.
Participants were classified as having severe DPN if they had a combination of neuropathic symptoms and signs of distal sensorimotor polyneuropathy with 2 or more of the following: absent distal sensation (as diagnosed by neurological examination from a board-certified neurologist and abnormal QST), unequivocally decreased or absent ankle reflexes, and severe abnormalities in NCSs in 2 or more separate nerves among the median, peroneal, and sural nerves as described earlier.
Exclusion criteria for all participants were 1) any systemic neuropathy other than DPN, 2) history of corneal disease or any eye surgery, 3) any neurodegenerative condition, such as Parkinson disease or multiple sclerosis, 4) history of stroke or cancer, 5) history of spinal stenosis or previous back surgery, and 6) not willing or able to provide consent.
Ophthalmologic evaluations: all participants underwent comprehensive ophthalmologic examination. Visual acuity was recorded using the Early Treatment Diabetic Retinopathy Study chart. 19 IOP was measured by Goldmann applanation tonometry. CCT was measured under topical anesthesia using an ultrasound pachymeter (DGH-550 Pachette 2; DGH Technology, Inc, Exton, PA).
Corneal confocal microscopy was performed using the Heidelberg Retina Tomograph-2 Rostock cornea module (Heidelberg Engineering, Heidelberg, Germany) to determine corneal layer thickness and endothelial cell count. 20 A drop of proparacaine hydrochloride 0.5% was given, followed by 
Statistical Analyses
Demographic characteristics were analyzed by computing frequencies and percentages for categorical variables and using a x 2 test to examine differences between groups. Mean values and SDs were calculated for continuous variables, and mean differences among groups were evaluated using AN-OVA for variables including age, body mass index, HbA1c levels, and the Student t test for the duration of diabetes. The effects of DPN status on CCT were analyzed using one-way ANOVA. Tukey honest significant difference (HSD) was used for pairwise group comparisons. All statistical analyses were performed using SAS 9.3 (Cary, NC).
RESULTS
Thirty-four participants with valid data sets were included in these analyses (9 controls, 16 patients with mild DPN, and 9 patients with severe DPN). The characteristics of the patients are shown in Table 1 . As expected, patients with severe DPN had longer diabetes duration and worse glucose control as documented by HbA1c levels compared with those with mild DPN. In addition, both groups with diabetes had higher BMI.
Mean CCT and stromal thickness among the 3 study groups are summarized in Table 2 . Evaluation of CCT measurements showed a statistically significant increase (ANOVA P = 0.0003) from controls to mild and severe DPN (Fig. 1) . Tukey HSD revealed that mean CCT was significantly increased in both mild and severe groups compared with controls. In addition, Tukey HSD also showed a significant increase in CCT from mild to severe DPN cases (P , 0.05).
In an effort to define the corneal regions most affected by the DPN status, confocal microscopy was performed. Stromal thickness showed a significant increase (ANOVA P = 0.045) in the mild and severe DPN groups compared with controls (Fig. 2) . By contrast, endothelial (ANOVA P = 0.257) and epithelial thicknesses (ANOVA P = 0.840) were not different among the 3 groups. The endothelial cell count did not differ significantly between the 3 study groups ( Table  2 , ANOVA P = 0.861).
Mean IOP among controls was 13.7 6 2.0 mm Hg, while the mild and severe DPN groups had a mean IOP of 
DISCUSSION
Our results demonstrated a progressive increase in CCT in patients with more severe DPN, which is consistent with previous studies on corneal thickness in diabetes. [6] [7] [8] [9] [10] [11] Our data showed an 11% increase in corneal thickness among severe DPN compared with controls, a 5.6% increase in corneal thickness among mild DPN compared with controls, and a 4.9% increase in CCT among severe DPN cases compared with mild cases. Based on the confocal microscopy results, this increase in CCT can be attributed to an increase in corneal stromal thickness with increasing DPN severity. In contrast to previous studies that reported an increase in IOP among patients with diabetes, 21, 22 IOP results in this study did not differ among the 3 groups. This discrepancy could be due to lower power associated with the sample size in this study.
DM is characterized by chronic hyperglycemia, which has been shown to cause nonenzymatic glycation of several tissues. 23 This glycation reaction leads to parallel changes in the nervous system and ocular tissues. Two postulated mechanisms for the increase in CCT among patients with diabetes are collagen cross-linking and stromal hydration. Regarding the first mechanism of collagen cross-linking, collagen fibers are known to undergo glycation under chronic hyperglycemic conditions. 24, 25 The corneal stroma, being rich in collagen, is a target of nonenzymatic glycation and accumulation of advanced glycation end products leading to subsequent collagen cross-linking. 26, 27 Collagen cross-linking could explain the protective effect of diabetes on keratoconus susceptibility and progression. 28 Regarding the second mechanism of stromal hydration, decreased endothelial cell density and altered endothelial structure lead to stromal hydration and corneal edema resulting in thicker corneas among patients with diabetes. 9, 10, 29, 30 In the small sample of participants in our study, the endothelial cell count did not differ among the cases and controls. In addition, visual acuities among the controls and DPN cases were not significantly different (Table 3) , indicative of lack of clinically significant corneal edema among the cases. Hence, we propose collagen crosslinking as the possible mechanism for thicker corneas among patients with diabetes. Future studies are needed to elucidate the molecular changes in the cornea and to identify the causative mechanism for thicker corneas among patients with diabetes.
CCT is an important factor for assessing the risk of openangle glaucoma. Although a thinner cornea is an independent risk factor for open-angle glaucoma, a thicker cornea offers protection against glaucoma progression. 13,31 Thus, thicker corneas among populations with diabetes may be viewed as potentially "protective" but associated with overestimation of IOP. Results from health care claims data and meta-analysis demonstrate that diabetes is a risk factor for glaucoma. 32, 33 Although it is clear that hyperglycemia has detrimental effects on retinal vasculature as a mechanism of diabetic retinopathy, 34, 35 there is a lack of detailed studies on the hyperglycemic effects on other ocular tissues. The strengths of this study include meticulous phenotyping of DPN status using objective measures including electrophysiology studies and clinical examination by a multidisciplinary team. To the best of our knowledge, this was the first study to examine corneal thickness from a DPN severity framework and also to isolate stromal thickness measurements among patients with diabetes. The main limitation of this study was a small sample size, which restricts the ability to detect smaller effects or differences. Lack of an additional control group consisting of patients with diabetes but without DPN is another limitation because this would have provided another population in which to evaluate the effect of DPN on CCT. However, observation of a significant CCT difference between mild and severe DPN and between normal controls and these 2 DPN groups is suggestive that DPN may play a role in CCT. Adjusting for additional factors such as BMI, HbA1c, and HDL that could potentially confound the association between CCT and DPN was not possible because of numerous missing data. Temporality of association and the causal relationship could not be established because of the cross-sectional nature of this study.
In conclusion, our study confirms increased corneal thickness in patients with diabetes. More importantly, our findings demonstrate an increased CCT that is confined to the stroma. The mechanisms of this stroma-mediated CCT change are currently not fully understood. Further studies are needed to fill this gap in knowledge to fully understand the spectrum of homeostatic tissue adaptation in early hyperglycemia to late pathophysiological consequences of uncontrolled diabetes.
